Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:69:1-46.
doi: 10.1016/bs.acc.2014.12.001. Epub 2015 Feb 7.

D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications

Affiliations
Review

D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications

John D Olson. Adv Clin Chem. 2015.

Abstract

D-dimer is the smallest fibrinolysis-specific degradation product found in the circulation. The origins, assays, and clinical use of D-dimer will be addressed. Hemostasis (platelet and vascular function, coagulation, fibrinolysis, hemostasis) is briefly reviewed. D-dimer assays are reviewed. The D-dimer is very sensitive to intravascular thrombus and may be markedly elevated in disseminated intravascular coagulation, acute aortic dissection, and pulmonary embolus. Because of its exquisite sensitivity, negative tests are useful in the exclusion venous thromboembolism. Elevations occur in normal pregnancy, rising two- to fourfold by delivery. D-dimer also rises with age, limiting its use in those >80 years old. There is a variable rise in D-dimer in active malignancy and indicates increased thrombosis risk in active disease. Elevated D-dimer following anticoagulation for a thrombotic event indicates increased risk of recurrent thrombosis. These and other issues are addressed.

Keywords: D-dimer; Deep venous thrombosis; Disseminated intravascular coagulation; Fibrinolysis; Pulmonary embolus.

PubMed Disclaimer

LinkOut - more resources